CAFFEINEAS A PROMISING ANTIFBROTIC AGENT AGAINST CCL4-INDUCED LIVER FIBROSIS

  • Mostafa Kamal Mohamed Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt
  • Marwa Mahmoud Khalaf Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt
  • Amira Morad Abo-youssef Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt
  • Ali Ahmed Abo-saif Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt

Abstract

Objective: Hepatic fibrosis is a wound-healing process in the liver with chronic injury and is characterized by an excess production and deposition of extracellular matrix (ECM) components. Our aim is to investigate the hepatoprotective effects of caffeine against CCL4-induced liver fibrosis in rats and to be compared with the reference standard N-acetylcysteine (NAC).

Methods: Rats were divided into 5 groups (n=8), the 1st group served as normal control, the 2nd group received corn oil, the 3rd group is a fibrosis control and the remaining two groups received in addition to CCL4, NAC (150 mg/kg/day) as a reference treatment and caffeine (15 mg/kg/day). At the end of experimental period the following parameters were measured, specific fibrosis biomarkers [hepatic transforming growth factor β1(TGF-β1) and hepatic hydroxyproline (HYP)], liver function biomarkers [serum alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin and albumin], lipid profile [serum triglycerides, total cholesterol, low density lipoprotein cholesterol (LDL-Ch) and high density lipoprotein cholesterol (HDL-Ch)], inflammatory biomarkers [serum tumor necrosis factor alpha (TNF-α), hepatic myeloperoxidase (MPO)], oxidative stress biomarkers [hepatic malondialdehyde (MDA), glutathione (GSH) and catalase (CAT)], relative liver body weight and liver histopathological study.

Results: Caffeine significantly improved all the aforementioned biochemical parameters and liver sections obtained from this group showed prominent histopathological improvement.

Conclusion: Caffeine hepatoprotective effects may be due to modulation of the fibrous scar formation, Improvement of liver function, Anti-inflammatory and antioxidant potentials.

Keywords: Liver fibrosis, Rat, CCL4, NAC, Caffeine

Downloads

Download data is not yet available.

References

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209–18.
2. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010;7:425–36.
3. Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000;35:665–72.
4. Rezaie A, Pashmforosh M, Karamallah M, Fazlara A, Haghighat N, Shahriari A. Hepatoprotective effects of caffeine on diethylnitrosamine induced liver injury in rtas. Bulg J Vet Med 2014;17:183–90.
5. Dranoff JA, Feld JJ, Lavoie EG, Fausther M. How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations. Hepatology 2014;60:464–7.
6. Ay H, Wk L, Hl C, Fk C, My G, Kk C, et al. Effect of celecoxib on experimental liver fibrosis in rat. Liver Int 2006;26:125–36.
7. Kamalakkannan N, Rukkumani R, Aruna K, Varma PS, Viswanathan P, Menon VP. Protective effect of N-Acetyl cysteine in carbon tetrachloride-induced hepatotoxicity in rats. Iran J Pharmacol Ther 2005;4:118–23.
8. Gordillo-Bastidas D, Oceguera-Contreras E, Salazar-Montes A, González-Cuevas J, Hernández-Ortega LD, Armendáriz-Borunda J. Nrf2 and snail-1 in the prevention of experimental liver fibrosis by caffeine. World J Gastroenterol 2013;19:9020–33.
9. Brouckaert P, Libert C, Everaerdt B, Takahashi N, Cauwels A, Fiers W. Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. Immunobiology 1993;187:317–29.
10. Bergmeyer HU, Horder M, Rej R. IFCC method for alanine aminotransferase and aspartate aminotransferase. J Clin Chem Clin Biochem 1976;24:481–510.
11. Watson D. A simple method for the determination of serum cholesterol. Clin Chim Acta 1960;5:637–43.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimationof the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
13. Fossati P, Principe L. Serum triglycerides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077–80.
14. Malloy HT, Evelyn KA. The determination of bilirubin with the photometric colorimeter. J Biol Chem 1937;119:481–90.
15. Doumas BT, Biggs HG. Standard methods of clinical chemistry. Academic Press NY; 1976. p. 7.
16. Blanchette F, Day R, Dong W, Laprise M, Dubois CM. TGF beta1 regulates gene expression of its own converting enzyme furin. Am Soc Clin Investig 1997;99:1974-83.
17. Patiyal SN, Katoch SS, Hill S. Tissue specific and variable collagen proliferation in swiss albino mice treated with clenbuterol. Physiol Res 2006;55:97–103.
18. Beutler E, Duron O, Kelly MB. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882–8.
19. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121–6.
20. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978;90:37–43.
21. Weiss SJ, Klein R, Slivka A, Wei M. Chlorination of taurine by human neutrophil. J Clin Invest 1982;70:598-607.
22. Branchroft GD, Steven A. Theory and practice of histological technique. London, 4th ed. Churchil Livingstone Publications; 1983. p. 99–112.
23. Furtado KS, Prado MG, Aguiar E, Silva MA, Dias MC, Rivelli DP, et al. Coffee and caffeine protect against liver injury induced by thioacetamide in male wistar rats. Basic Clin Pharmacol Toxicol 2012;111:339–47.
24. Shin J, Wang J, Kang J. Experimental evidence for the protective effects of coffee against liver fibrosis in SD rats. Soc Chem Ind 2010;90:450–5.
25. Barcelos RP, Souza MA, Amaral GP, Stefanello ST, Bresciani G, Fighera MR, et al. Caffeine intake may modulate inflammation markers in trained rats. Nutrients 2014;6:1678–90.
26. Olza J, Aguilera CM, Gil-Campos M, Leis R, Bueno G, Martinez-Jimenez MD, et al. Myeloperoxidase Is an early biomarker risk in prepubertal obese children. Diabetes Care 2012;35:2373–6.
27. Abd El-ghany MA, Nagib RM, El-Saiyed HM. Hypolipidemic effect of caffeine beverages in fatty liver injured rats. J Appl Sci Res 2012;8:1502–9.
28. Cichoż-lach H, Michalak A. Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol 2014;20:8082–91.
29. Paşaoğlu H, Ebru F, Demİr O, Demİrtaş CY, Hussein A. Th e effect of caffeine on oxidative stress in liver and heart tissues of rats. Turk J Med Sci 2011;41:665–71.
30. Wang H, Guan W, Yang W, Wang Q, Zhao H, Yang F, et al. Caffeine inhibits the activation of hepatic stellate cells induced by acetaldehyde via adenosine A2A receptor mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK signal pathway. PLOS One 2014;9:1–11.
Statistics
338 Views | 587 Downloads
Citatons
How to Cite
Mohamed, M. K., M. M. Khalaf, A. M. Abo-youssef, and A. A. Abo-saif. “CAFFEINEAS A PROMISING ANTIFBROTIC AGENT AGAINST CCL4-INDUCED LIVER FIBROSIS”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 9, no. 6, June 2017, pp. 42-47, doi:10.22159/ijpps.2017v9i6.17143.
Section
Original Article(s)